Event Information
Event Topic:
Evolution of Neurovascular Interventional Business Over the Past Two Decades
Event Description:
Detachable coil, which was pioneered to treat brain aneurysms, remained the most notable product in neuro-intervention until the early 2000s. Brain aneurysms are responsible only for less than 13% of the strokes occurring in the world. The remaining 87% are acute ischemic stroke, which occurs, when clot, often formed elsewhere in the vasculature, travels to the brain, and blocks the supply of oxygenated blood to the brain. The first product to revascularize patients with acute ischemic stroke interventionally was launched in the US in early 2000s, however, it wasn’t until 2012, when a clot retriever was cleared for sale in the US, that the acute ischemic stroke interventions begun to take off as a mainstream therapy. Since then, several clot retrieval products have entered the market that have, collectively, revolutionized the field of acute ischemic stroke. The safety and effectiveness of the treatments brought forward by these devices is remarkable. The talk will provide a background on various neurovascular diseases and cover the evolution of interventional treatments for these diseases including how they have shaped the market as it stands today.
Date/Time:
Date(s) - 10/12/21
6:20 pm - 8:45 pm
Event Location:
Zoom talk: https://us02web.zoom.us/j/88274227563:
Speaker Information
Event Speaker:
Sanjay Shrivastava
Event Speaker Title:
CEO
Event Speaker Company:
Innova Vascular, Inc.
Event Speaker Bio:
Dr. Sanjay Shrivastava is the founder and CEO of Innova Medical, Inc., which is a startup company involved in developing a set of medical devices for an under-served cardiovascular disease and, is funded largely by a publicly traded medical device company. Previously, Sanjay was a senior director, business development (BD) at Biosense Webster, Inc. (BWI), a $3b annual revenue company within J&J, where he was responsible for BD and served on the leadership team of BWI. Sanjay also worked at Medtronic Neurovascular for nearly 10 years, where he was a director, global marketing for 6 years and director, R&D for 4 years. Additionally, Sanjay was a vice president, upstream marketing and strategy at BTG, plc, a London based publicly traded company, which is now part of Boston Scientific. Sanjay also cofounded BlackSwan Vascular--a clinical stage medical device startup company, where he serves on the board of directors. In 2020, BlackSwan Vascular, Inc. entered in a strategic alliance with Sirtex Medical. Sanjay serves as a member of the board of directors at enVVeno Medical Corporation, which is a Nasdaq traded medical device company headquartered in Irvine, CA and engaged in developing a novel venous valve. In his corporate roles Sanjay received several key awards including the president’s club award for marketer of the year in 2015, national impact award from U.S. sales in 2013, best project team award in 2012, innovator of the year award in 2008 and was selected among a few leaders who use innovative approaches to get results via an anonymous survey of employees in 2014. Sanjay holds 30 issued US patents and numerous International patents in medical devices and has edited two books including one titled “Medical Device Materials” published by ASM International. He was named among 100 Notable People in Medical Device Industry by the prestigious MD&DI (Medical Devices and Diagnostics Industry) magazine. He has been an invited speaker at clinical, business, and engineering conferences to speak about medical device innovation and commercialization. Sanjay holds a doctorate in materials science and engineering from the University of Florida and a bachelor’s from the Indian Institute of Technology.
Event Details
Cost:
$0
Add To Calendar
